“…The clinical characteristics of MS infection are well known (Catania et al, 2016a;Sun et al, 2017;Ball et al, 2018;Kordafshari et al, 2019;Lorenc et al, 2019;Wu et al, 2019), and a number of genomic, proteomic, phenotype microarrays, and other analyses have been conducted. However, only a few MS proteins, including variable lipoprotein hemagglutinin (Narat et al, 1998;Lavric et al, 2007), cysteine protease (Cizelj et al, 2011), neuraminidase (Bercic et al, 2011), the putative nuclease MS53_0284 (Vasconcelos et al, 2005;Cizelj et al, 2016), and matrix metalloproteinase-2 (MMP-2) (Cizelj et al, 2016), have been identified as virulence determinants. In terms of host-pathogen interactions, Goret et al (2017) showed that M. hominis lipoproteins played a role in the activation of human dendritic cells and their immune responses.…”